论文信息 - Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models - 字舞流文

Antitumor Efficacy of Dual Blockade of EGFR Signaling by Osimertinib in Combination With Selumetinib or Cetuximab in Activated EGFR Human NCLC Tumor Models

F. Ciardiello | G. Troncone | T. Troiani | M. Castellone | C. D. Della Corte | E. Martinelli | F. Morgillo | P. Petronini | R. Alfieri | U. Malapelle | E. Vigliar | C. Cardone | S. La Monica | F. Pepe | V. Ciaramella